SEARCH

SEARCH BY CITATION

References

  • Anderson, L. & Seilhamer, J. (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis, 18, 533537.
  • Chauhan, D. & Anderson, K.C. (2003) Mechanisms of cell death and survival in multiple myeloma (MM): therapeutic implications. Apoptosis, 8, 337343.
  • Chauhan, D., Hideshima, T., Pandey, P., Treon, S., Teoh, G., Raje, N., Rosen, S., Krett, N., Husson, H., Avraham, S., Kharbanda, S. & Anderson, K.C. (1999) RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells. Oncogene, 18, 67336740.
  • Chauhan, D., Hideshima, T., Rosen, S., Reed, J.C., Kharbanda, S. & Anderson, K.C. (2001) Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells. Journal of Biological Chemistry, 276, 2445324456.
  • Chauhan, D., Auclair, D., Robinson, E.K., Hideshima, T., Li, G., Podar, K., Gupta, D., Richardson, P., Schlossman, R.L., Krett, N., Chen, L.B., Munshi, N.C. & Anderson, K.C. (2002) Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays. Oncogene, 21, 13461358.
  • Craven, R.A., Jackson, D.H., Selby, P.J. & Banks, R.E. (2002) Increased protein entry together with improved focussing using a combined IPGphor/multiphor approach. Proteomics, 2, 10611063.
  • Davies, T.H., Ning, Y.M. & Sanchez, E.R. (2002) A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. Journal of Biological Chemistry, 277, 45974600.
  • De Bosscher, K., Vanden Berghe, W. & Haegeman, G. (2000a) Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. Journal of Neuroimmunology, 109, 1622.
  • De Bosscher, K., Vanden Berghe, W., Vermeulen, L., Plaisance, S., Boone, E. & Haegeman, G. (2000b) Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proceedings of the National Acadamey of Science United States of America, 97, 39193924.
  • Denny, W.B., Valentine, D.L., Reynolds, P.D., Smith, D.F. & Scammell, J.G. (2000) Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology, 141, 41074113.
  • Ferri, K.F. & Kroemer, G. (2001) Mitrochondria – the suicide organelles. Bioessays, 23, 1115.
  • Goldman-Leikin, R.E., Salwen, H.R., Herst, C.V., Variakojis, D., Bian, M.L., Le Beau, M.M., Selvanayagan, P., Marder, R., Anderson, R. & Weitzman, S. (1989) Characterization of a novel myeloma cell line, MM.1. Journal of Laboratory Clinical Medicine, 113, 335345.
  • Greenstein, S., Krett, N.L., Kurosawa, Y., Ma, C., Chauhan, D., Hideshima, T., Anderson, K.C. & Rosen, S.T. (2003) Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells. Experimental Hematology, 31, 271282.
  • Hideshima, T., Nakamura, N., Chauhan, D. & Anderson, K.C. (2001) Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene, 20, 59916000.
  • Karkera, J.D., Taymans, S.E., Turner, G., Yoshikawa, T., Detera-Wadleigh, S.D. & Wadleigh, R.G. (1997) Deletion of a consensus oestrogen response element half-site in the glucocorticoid receptor of human multiple myeloma. British Journal of Haematology, 99, 372374.
  • Medh, R.D., Wang, A., Zhou, F. & Thompson, E.B. (2001) Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells. Oncogene, 20, 46294639.
  • Mitsiades, C., Mitsidaes, N., McMullan, C.J., Poulaki, V., Davies, F.E., Morgan, G., Akiyama, N., Shringapure, R., Munshi, N.C., Richardson, P.G., Hideshima, T., Chauhan, D., Gu, X., Bailey, C., Joseph, M., Libermann, T.A., Rosen, N.S. & Anderson, K.C. (2006) Anti-myeloma activity of heat shock protein 90 inhibition. Blood, 107, 10921100.
  • Moalli, P.A., Pillay, S., Weiner, D., Leikin, R. & Rosen, S.T. (1992) A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Blood, 79, 213222.
  • Morgan, G. (2001) Myeloma. In: Oxford Textbook of Oncology, 2nd edn (ed. by R.L.Souhami, I.Tannock, P.Hohenberger & J.C.Horiot), pp. 24192456. Oxford University Press, Oxford.
  • Pandey, P., Avraham, S., Kumar, S., Nakazawa, A., Place, A., Ghanem, L., Rana, A., Kumar, V., Majunder, P.K., Avraham, H., Davis, R.J. & Kharbanda, S. (1999) Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. Journal of Biological Chemistry, 274, 1014010144.
  • Pollet, J.B., Trudel, S., Stern, D., Li, Z.H. & Stewart, A.K. (2002) Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistance. Blood, 100, 38193821.
  • Pratt, W.B. & Toft, D.O. (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrinology Reviews, 18, 306360.
  • Reynolds, P.D., Ruan, Y., Smith, D.F. & Scammell, J.G. (1999) Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. Journal of Clinical Endocrinology and Metabolism, 84, 663669.
  • Richardson, P.G., Schlossman, R.L., Weller, E., Hideshima, T., Mitsiades, C., Davies, F., Le Blanc, R., Catley, L.P., Doss, D., Kelly, K., McKenney, M., Mechlowicz, J., Freeman, A., Deocampo, R., Rich, R., Ryoo, J.J., Chauhan, D., Balinski, K., Zeldis, J. & Anderson, K.C. (2002) Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood, 100, 30633067.
  • Richardson, P.G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S.V., Srkalovic, G., Alsina, M., Alexanian, R., Siegel, D., Orlowski, R.Z., Kuter, D., Limentani, S.A., Lee, S., Hideshima, T., Esseltine, D.L., Kauffman, M., Adams, J., Schenkein, D.P. & Anderson, K.C. (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. New England Journal of Medicine, 348, 26092617.
  • Samson, D., Gaminara, E., Newland, A., Van de Pette, J., Kearney, J., McCarthy, D., Joyner, M., Aston, L., Mitchell, T. & Hamon, M. (1989) Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma. Lancet, 2, 882885.
  • Shi, Y. (2001) A structural view of mitochondria-mediated apoptosis. Nature Structural Biology, 8, 394401.
  • Tago, K., Tsukahara, F., Naruse, M., Yoshioka, T. & Takano, K. (2004) Hsp90 inhibitrs attenuate the effect of dexamethasone on activated NF-kapaB and AP-1. Life Sciences, 74, 19811992.
  • Tokiwa, G., Dikic, I., Lev, S. & Schlessinger, J. (1996) Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science, 273, 792794.
  • Tu, Y., Gardner, A. & Lichtenstein, A. (2000) The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Research, 60, 67636770.
  • Unwin, R.D., Craven, R.A., Harnden, P., Hanrahan, S., Totty, N., Knowles, M., Eardley, L., Selby, P.J. & Banks, R.E. (2003) Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics, 3, 16201632.
  • Vermeer, H., Hendriks-Stegeman, B.I., Van Der Burg, B., Buul-Offers, S.C. & Jansen, M. (2003) Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. Journal of Clinical Endocrinology and Metabolism, 88, 277284.